| Rachel P Baer, MD | |
|
745 Fletcher Dr, #302, Elgin, IL 60123 | |
| (847) 695-6600 | |
| (847) 695-4279 |
| Full Name | Rachel P Baer |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 44 Years |
| Location | 745 Fletcher Dr, Elgin, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437110707 | NPI | - | NPPES |
| 036102748 | Medicaid | IL | |
| 4515536 | Other | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | 036102743 (Illinois) | Secondary |
| 208600000X | Surgery | 036102743 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advocate Sherman Hospital | Elgin, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advocate Health And Hospitals Corporation | 7810800935 | 2422 |
News Archive
On a crisp sunny day, Tyson Toledo, a precocious 5-year-old boy, hobbled into a private health clinic to have his infected foot examined.
The Washington Post reports on the challenges involved in fielding a team of health exchange navigators to help people work through their choices and the process. Meanwhile, MedPage Today reports on comments made by Health and Human Services Secretary Kathleen Sebelius regarding the "obligation" providers have to try new payment models.
Shire plc today announced that the 13-week Phase 2 IMAGO trial of its investigational compound SHP625 (LUM001) did not meet the primary or secondary endpoints in the study of 20 pediatric patients with Alagille syndrome (ALGS), a rare, life-threatening genetic disorder that presents with chronic cholestasis (accumulation of bile acids in the liver) and severe pruritus (itching).
Following gene therapy, the retina can restructure itself and regain normal light responses, according to research in mice published in JNeurosci.
› Verified 3 days ago
| Entity Name | Advocate Health And Hospitals Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700824455 PECOS PAC ID: 7810800935 Enrollment ID: O20031106000064 |
News Archive
On a crisp sunny day, Tyson Toledo, a precocious 5-year-old boy, hobbled into a private health clinic to have his infected foot examined.
The Washington Post reports on the challenges involved in fielding a team of health exchange navigators to help people work through their choices and the process. Meanwhile, MedPage Today reports on comments made by Health and Human Services Secretary Kathleen Sebelius regarding the "obligation" providers have to try new payment models.
Shire plc today announced that the 13-week Phase 2 IMAGO trial of its investigational compound SHP625 (LUM001) did not meet the primary or secondary endpoints in the study of 20 pediatric patients with Alagille syndrome (ALGS), a rare, life-threatening genetic disorder that presents with chronic cholestasis (accumulation of bile acids in the liver) and severe pruritus (itching).
Following gene therapy, the retina can restructure itself and regain normal light responses, according to research in mice published in JNeurosci.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachel P Baer, MD 29373 Network Pl, Chicago, IL 60673-1293 Ph: (847) 390-5900 | Rachel P Baer, MD 745 Fletcher Dr, #302, Elgin, IL 60123 Ph: (847) 695-6600 |
News Archive
On a crisp sunny day, Tyson Toledo, a precocious 5-year-old boy, hobbled into a private health clinic to have his infected foot examined.
The Washington Post reports on the challenges involved in fielding a team of health exchange navigators to help people work through their choices and the process. Meanwhile, MedPage Today reports on comments made by Health and Human Services Secretary Kathleen Sebelius regarding the "obligation" providers have to try new payment models.
Shire plc today announced that the 13-week Phase 2 IMAGO trial of its investigational compound SHP625 (LUM001) did not meet the primary or secondary endpoints in the study of 20 pediatric patients with Alagille syndrome (ALGS), a rare, life-threatening genetic disorder that presents with chronic cholestasis (accumulation of bile acids in the liver) and severe pruritus (itching).
Following gene therapy, the retina can restructure itself and regain normal light responses, according to research in mice published in JNeurosci.
› Verified 3 days ago
Dr. Nicholas Kunio, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 745 Fletcher Dr, Elgin, IL 60123 Phone: 847-695-6600 Fax: 847-695-4279 | |
Thomas H Fendon, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 901 Center St, Suite 3002, Elgin, IL 60120 Phone: 847-531-6340 Fax: 847-531-6344 | |
Dr. Emilie Robinson, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1975 Lin Lor Ln Ste 155, Elgin, IL 60123 Phone: 847-981-3680 | |
Dr. Cynthia N Steimle, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1435 N Randall Rd, Suite 209, Elgin, IL 60123 Phone: 847-695-1620 Fax: 847-695-1954 | |
Dr. Irene I Wu, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 163 S Randall Rd, Elgin, IL 60123 Phone: 847-406-1007 Fax: 847-695-2377 | |
Michael William Fremgen, Surgery Medicare: Accepting Medicare Assignments Practice Location: 745 Fletcher Dr Ste 302, Elgin, IL 60123 Phone: 847-695-6600 |